Sun Pharma acquires Organon
Sun Pharma agreed to acquire Organon. Reported deal value: $10B. Status: Pending. Sector: pharmaceuticals. Target headquarters context: Jersey City, New Jersey, United States.
This page summarizes publicly available information about the transaction as of 2026-01-31. Figures and status may change as filings and press coverage update.
Abhijeet Singh ET Pharma Updated On Jan 31, 2026 at 10:20 PM IST New Delhi: Amid speculation” of making a potential bid to acquire US-based Organon for an enterprise value of $10–14 billion , Sun Pharma Founder and Executive Chairman Dilip Shanghvi said the company wants to remain disciplined in its acquisition strategy
Deal timeline
This transaction is classified in pharmaceuticals with a reported deal value of $10B. Figures and status may change as sources update.